Treace Medical Concepts Inc. Company Profile
NASDAQ: TMCIHealth CareMedical/Dental InstrumentsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Treace Medical Concepts at a glance
Treace Medical Concepts Inc. (NASDAQ: TMCI) is a Medical/Dental Instruments company in the Health Care sector headquartered in Ponte Vedra, FL. Treace Medical Concepts is led by Mr. John T. Treace and employs about 450 people. The company's shares have traded publicly since 2021.
At a market capitalization of $253.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001630627, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Treace Medical Concepts do?
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Business description based on the company's public filings.
Company information
- Legal name
- Treace Medical Concepts Inc.
- Ticker
- NASDAQ: TMCI
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. John T. Treace
- Employees
- 450
- Headquarters
- 100 Palmetto Park Place, Ponte Vedra, FL, United States
- Phone
- 904 373 5940
- Website
- treace.com
- IPO year
- 2021
- Market cap
- $252.98M
- SEC CIK
- 0001630627
Companies similar to Treace Medical Concepts
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PROFProfound Medical Corp. | 6.91 | +21.65% | $252.49M | vs TMCI |
| ANIKAnika Therapeutics Inc. | 19.23 | -1.54% | $257.35M | vs TMCI |
| OSUROraSure Technologies Inc. | 3.80 | +1.74% | $261.74M | vs TMCI |
| INFUInfuSystems Holdings Inc. | 13.41 | +0.60% | $267.09M | vs TMCI |
| MOBIMobia Medical Inc. | 8.56 | +0.59% | $284.97M | vs TMCI |
| KTWOK2 Capital Acquisition Corporation Class A | 10.07 | 0.00% | $201.81M | vs TMCI |
| PDEXPro-Dex Inc. | 62.21 | -0.94% | $201.14M | vs TMCI |
| CLPTClearPoint Neuro Inc. | 10.49 | -1.59% | $319.99M | vs TMCI |